Publication | Closed Access
Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma
77
Citations
22
References
2006
Year
UrologyMedicinePhase Ii StudyPathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyFirst Line Treatment
| Year | Citations | |
|---|---|---|
Page 1
Page 1